heart diseaes | sciencenewsnet.in

Breaking News

Roy Choi Will Speak to Cal State Fullerton’s Class of 2024

Compact quantum light processing

Researchers develop a new way to safely boost immune cells to fight cancer

Alcohol-Induced Blackouts May Be Linked to How a Person Drinks, Not Just How Much

Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

RCT finds calories may be more important than meal timing when it comes to weight loss

Newer antibiotics underprescribed for highly resistant infections

Chula Ranks No.1 in Thailand for 32 Subjects in the QS World University Rankings by Subject 2024

Researchers to share expertise at international conference on mine water, reclamation

20 Apr, 2024

Pilot Randomized Trial Demonstrates that PCI of Non-Flow-Limiting Vulnerable Plaques May be Safe with Favorable Long-Term Clinical Outcomes

October 14, 2020 sarah JonasResearch Results

New data from PROSPECT ABSORB, a pilot randomized trial of percutaneous coronary intervention (PCI) of non-flow-limiting vulnerable plaques in native coronary arteries, found that PCI was safe, substantially enlarged follow-up lumen areas, and was associated with favorable long-term clinical outcomes.